Drug Profile
Research programme: antibody-drug conjugates - Eli Lilly and Company
Alternative Names: Lilly 1Latest Information Update: 04 Jun 2021
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Drug conjugates; Immunoconjugates; Immunotoxins; Maytansinoids; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer